Feedback

Evaluating the role of astragalus polysaccharide in modulating immune infiltration and enhancing prognostic biomarkers in pediatric acute myeloid leukemia

Affiliation
Clinical laboratory center ,Children’s Hospital of Shanxi Province (Women Health Center of Shanxi Province) ,Taiyuan ,China
He, Min-Hui;
Affiliation
Department of Internal Medicine ,Children’s Hospital of Shanxi Province (Women Health Center of Shanxi Province) ,Taiyuan ,China
Zhang, Xian-Hui;
Affiliation
Hematology Research Laboratory ,Shengjing Hospital Affiliated to China Medical University ,Shenyang ,China
Zhang, Ji-Hong;
Affiliation
Department of Pathology ,Stanford University School of Medicine ,Palo Alto ,CA ,United States
Pan, Jie;
Affiliation
Department of Clinical Laboratory ,Taiyuan Central Hospital (Peking University First Hospital Taiyuan Hospital) ,Taiyuan, Shanx ,China
Yang, Chao

Background Childhood acute myeloid leukemia (AML) constitutes a significant proportion of pediatric malignancies, with current treatment options remaining limited. This study aimed to investigate the role of Astragalus polysaccharide (APS) in immune infiltration and prognosis of pediatric AML. Methods Differentially expressed genes (DEGs) were identified from the GEO database (dataset GSE2191), and APS-related genes (APSRGs) were obtained from the Swiss Target Prediction platform. DEGs with |logFC| > 1 and p < 0.05 were intersected with APSRGs to identify APS-related differentially expressed genes (APSRDEGs), visualized using a Venn diagram. A protein-protein interaction (PPI) network analysis was conducted to identify hub genes. Gene Ontology (GO) and KEGG enrichment analyses were performed to determine biological processes (BP), cellular components (CC), molecular functions (MF), and relevant pathways associated with the hub genes. Correlation analysis, receiver operating characteristic (ROC) curve analysis, and immune infiltration analysis were conducted to assess the relationship between hub genes and pediatric AML. Results The GSE2191 dataset was divided into pediatric AML (PAML) and control groups. A total of 1,881 DEGs were identified, of which 20 were APSRDEGs. PPI network analysis revealed that 13 APSRDEGs were interconnected, and nine hub genes were identified: CASP3 , PTPRC , ELANE , HMOX1 , CHUK , FLT1 , JAK3 , CTSL , and AURKA . GO and KEGG enrichment analyses indicated that these genes were significantly associated with key biological processes, cellular components, molecular functions, and pathways involved in AML. ROC curve analysis revealed that the expression levels of the nine hub genes differed significantly between the PAML and control groups. Immune infiltration analysis demonstrated a strong correlation between several hub genes and immune cells, with HMOX1 showing the strongest positive correlation with neutrophils. Conclusion This study identified nine hub genes related to APS in pediatric AML. These findings suggest that APS may significantly affect immune infiltration and prognosis in pediatric AML, highlighting its potential as a therapeutic modulator for the disease.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2025 He, Zhang, Zhang, Pan and Yang.

Use and reproduction: